Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2022 was -16.37% (a -224.49% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -127.91%
- Annual Research and Development (R&D) Expenses Growth for 2021 was -3.4% (a -105.97% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 56.91% (a 2213.41% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 2.46% (a -13.07% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2022 was 26.8% (a -43.97% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -11.67% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| 26.8% | 47.83% | 47.84% | 30.34% |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Biofrontera AG Sponsored ADR
Most recent Research and Development (R&D) Expenses Growthof BFAGY including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | -16.37% | 13.15% | – |
| 2021 | 65.56% | 58.66% | 57.65% | 9.78% | -3.4% |
| 2020 | 7.19% | 19.24% | -1.99% | 20.62% | 2.46% |
| 2019 | – | 29.66% | -17.24% | 2.03% | -1.02% |
| 2018 | – | – | – | -17.09% | 13.27% |
| 2017 | – | – | -22.88% | 20.83% | 28.96% |
| 2016 | – | – | – | – | 19.55% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic